期刊文献+

多位点序列分型技术在鲍曼不动杆菌同源性分析中的应用 被引量:15

Application of multilocus sequence typing technique in homology analysis of Acinetobacter baumannii
下载PDF
导出
摘要 目的了解我院ICU病房鲍曼不动杆菌的分子流行特征,分析其基因同源性,为医院感染控制提供实验室依据。方法收集暨南大学附属第一医院ICU病房分离的107株鲍曼不动杆菌,采用多位点序列分型(multilocus sequence typing,MLST)技术,PCR扩增gltA、gyrB、gdhB、recA、cpn60、gpi和rpoD 7个管家基因片段,测序结果与PubMLST数据库比对分析,利用eBURST软件绘制不同基因型之间的进化关系图。结果 107株鲍曼不动杆菌被分为4个基因型,分别是ST-136(31株)、ST-195(7株)、ST-208(58株)和一个新的基因型(11株),其中ST136、ST195和ST208基因型具有同源相关性。结论我院ICU病房的鲍曼不动杆菌具有水平传播特征,多位点序列分型技术可用于临床鲍曼不动杆菌的基因分型。 Objective To investigate the molecular epidemiology characteristic and analyze gene homology ofAcinetobacter baumannii isolated in ICU ward of our hospital, so as to provide evidence for nosocomial infection control. Methods 107 A. baumannii stains were collected from ICU ward in the first affiliated hospital of Jinan university, and genotype was identified by multilocus sequence typing (MLST) technique, gltA, gyrB, gdhB, recA, cpn60, gpi and rpoD housekeeping genes were detected by PCR amplification. PCR results were sequenced and compared with PubMLST databases. Evolutionary diagram was generated with eBURST software. Results Four genotypes were identified among 107 A. baumannii stains: ST-136 (31strains), ST-195 (7 strains), ST-208 (58 strains) and a new genotype (11 strains). ST136, ST195, and ST208 have the homologous relevance. Conclusion Acinetobacter baumannii isolated in ICU ward of our hospital had the level dissemination characteristic, and MLST could be used in genotyping of clinical Acinetobacter baumannii.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第5期360-362,共3页 Chinese Journal of Antibiotics
关键词 鲍曼不动杆菌 多位点序列分型技术 同源性 Acinetobacter baumannii Multilocus sequence typing Homology
  • 相关文献

参考文献6

  • 1Kempf M, Rolain J M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options [J]. Int JAntimicrob Agents, 2012, 39(2): 105-114.
  • 2Bartual S G, Seifert H, Hippler C, et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii[J]. J Clin Microbiol, 2005, 43(9): 4382-4390.
  • 3Zhong Q, Xu W, Wu Y, et al. Clonal spread of carbapenem non-susceptible Acinetobacter baumannii in an intensive care unit in a teaching hospital in China [J]. Ann Lab Med, 2012, 32(6): 413-419.
  • 4胡永强,贾蓓,李崇智,刘成伟,黄文祥,袁喆,朱卫民,尹乐.医院感染鲍曼不动杆菌耐消毒剂基因及同源性分析[J].中国抗生素杂志,2012,37(5):348-351. 被引量:11
  • 5Zarrilli R, Giarmouli M, Rocco F, et al. Genome sequences of three Acinetobacter baumannii strains assigned to the multilocus sequence typing genotypes ST2, ST25, and ST78 [J]. JBacteriol, 2011, 193(9): 2359-2360.
  • 6徐杰,郭洁,王丽丽,王玉飞,苑锡铜,袁静,宋宏彬,黄留玉,张宁,陈永德,陈泽良,刘世巍.125株耐碳青霉烯类抗菌药物鲍氏不动杆菌多位点序列分型[J].中华医院感染学杂志,2012,22(6):1101-1103. 被引量:5

二级参考文献14

  • 1应春妹,翁文浩.鲍曼不动杆菌多重耐药机制研究进展[J].检验医学,2007,22(2):208-212. 被引量:68
  • 2Perez F,Hujer AM,Hujer KM,et al.Global challenge ofmultidrug-resistant Acinetobacter baumannii[J].AntimicrobAgents Chemother,2007,51(10):3471-3484.
  • 3Karlowsky JA,Draghi DC,Jones ME,et al.Surveillance forantimicrobial susceptibility among clinical isolates of Pseudo-monas aeruginosa and Acinetobacter baumannii from hospital-ized patients in the United States,1998to 2001[J].Antimi-crob agents chemother,2003,47(5):1681-1688.
  • 4Bartual SG,Seifert H,Hippler C,et al.Development of amultilocus sequence typing scheme for characterization of clini-cal isolates of Acinetobacter baumannii[J].J Clin Microbiol,2005,43(9):4382-4390.
  • 5Chen Z,Qlu S,Wang Y,et al.Coexistence of blaNDM-1with the Prevalent blaOXA23and blaIMP in Pan-drug Resist-ant Acinetobacter baumannii Isolates in China[J].Clin InfectDis,2011,52(5):692-693.
  • 6Corvec S,Caroff N,Espaze E,et al.AmpC cephalosporinasehyperproduction in Acinetobacter baumannii clinical strains[J].J Antimicrob Chemother,2003,52(4):629-635.
  • 7Segal H,Nelson EC,Elisha BG.Genetic environment andtranscription of ampC in an Acinetobacter baumannii clinical i-solate[J].Antimicrob Agents Chemother,2004,48(2):612-614.
  • 8Gaze W H, Abdousiamn, Hawkey P M, et al. Incidence of class 1 integrons in a quaternary ammonium compound- polluted environment[J]. Antimicrob Agents Chemother, 2005, 49(5): 1802-1807.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement[S]. CLSI documents M100-S20. CLSI, 2010.
  • 10Dent L L, Marshall D R, Pratap S, et al. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis, 2010, 10:196.

共引文献13

同被引文献86

  • 1余方友,李美兰,林晓梅,周铁丽,陈增强,王薇薇,戴美杰,陈坚,刘桂胜.耐甲氧西林金黄色葡萄球菌的SCCmec基因型及耐药谱研究[J].中华微生物学和免疫学杂志,2006,26(6):543-543. 被引量:11
  • 2马筱玲,张涛,戴媛媛,徐元宏.耐万古霉素金黄色葡萄球菌生物学特性改变与细菌鉴定[J].临床输血与检验,2006,8(4):282-285. 被引量:4
  • 3王瑶,徐英春.2004—2005年中国CHINET鲍曼不动杆菌耐药性分析[J].中国感染与化疗杂志,2007,7(4):279-282. 被引量:71
  • 4李敏,李东光,王美菡,郭健.食物中呕吐毒素Cereulide特性及检测研究进展[J].中国公共卫生,2007,23(9):1116-1117. 被引量:5
  • 5FuY,ZhouJ,ZhouH,etal.WidedisseminationofOXA-23-producing carbapenem-resistantAcinetobacterbaumanniiclonalcomplex22inmultiplecitiesofChina[J].JAntimicrobChemother,2010,65(4):644-650.
  • 6ClinicalandLaboratoryStandardsInstitute.Performancestandards for antimicrobialsusceptibility testing:twenty-firstinformationalsupplement[S]. M100-S22,CLSI,2012.
  • 7PelegAY,SeifertH,PatersonDL,etal.Acinetobacterbaumannii:emergenceofasuccessfulpathogen[J].ClinMicrobiolRev,2008,21(3):538-582.
  • 8BernardsAT,HarinckHI,DijkshoornL,etal.PersistentAcinetobacterbaumannii-Lookinsideyourmedicalequipment [J]. Infect Control HospEpidemiol,2004,25(11):1002-1004.
  • 9ClímacoEC,OliveiraML,Pitondo-SilvaA,etal.Clonalcomplexes104,109and113playingamajorrolein thedissemination ofOXA-carbapenemase-producingAcinetobacterbaumanniiinSoutheastBrazil[J].InfectGenetEvol,2013,19:127-133.
  • 10HuangL, SunL, YanY.ClonalspreadofcarbapenemresistantAcinetobacterbaumanniiST92inaChinesehospitalduringa6-yearperiod[J].JMicrobiol,2013,51(1):113-117.

引证文献15

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部